Sökning: WFRF:(Sternberg Cora N.)
> Tammela Teuvo L.J. >
Enzalutamide in Men...
Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer : Extended Analysis of the Phase 3 PREVAIL Study
-
- Beer, Tomasz M. (författare)
- Oregon Health & Science University
-
- Armstrong, Andrew J (författare)
- Duke University
-
- Rathkopf, Dana E (författare)
- Memorial Sloan-Kettering Cancer Center
-
visa fler...
-
- Loriot, Yohann (författare)
- Institut Gustave Roussy
-
- Sternberg, Cora N. (författare)
- Azienda Ospedaliera San Camillo Forlanini
-
- Higano, Celestia S. (författare)
- University of Washington
-
- Iversen, Peter (författare)
- Copenhagen University Hospital
-
- Evans, Christopher P. (författare)
- University of California, Davis
-
- Kim, Choung Soo (författare)
- Asan Medical Center
-
- Kimura, Go (författare)
- Nippon Medical School
-
- Miller, Kurt (författare)
- Charité - University Medicine Berlin
-
- Saad, Fred (författare)
- University Of Quebec In Montreal
-
- Bjartell, Anders S. (författare)
- Lund University,Lunds universitet,Skåne University Hospital
-
- Borre, Michael (författare)
- Aarhus University Hospital
-
- Mulders, Peter (författare)
- Radboud University Nijmegen
-
- Tammela, Teuvo L J (författare)
- Tampere University Hospital,University of Tampere
-
- Parli, Teresa (författare)
- Medivation Inc.
-
- Sari, Suha (författare)
- Medivation Inc.
-
- van Os, Steve (författare)
- Astellas Pharma Europe
-
- Theeuwes, Ad (författare)
- Astellas Pharma Europe
-
- Tombal, Bertrand (författare)
- Saint-Luc University Hospital
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2017
- 2017
- Engelska 4 s.
-
Ingår i: European Urology. - : Elsevier BV. - 0302-2838. ; 71:2, s. 151-154
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://europepmc.or...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Enzalutamide significantly improved radiographic progression-free survival (rPFS) and overall survival (OS) among men with chemotherapy-naïve metastatic castration-resistant prostate cancer at the prespecified interim analysis of PREVAIL, a phase 3, double-blind, randomized study. We evaluated the longer-term efficacy and safety of enzalutamide up to the prespecified number of deaths in the final analysis, which included an additional 20 mo of follow-up for investigator-assessed rPFS, 9 mo of follow-up for OS, and 4 mo of follow-up for safety. Enzalutamide reduced the risk of radiographic progression or death by 68% (hazard ratio [HR] 0.32, 95% confidence interval [CI] 0.28–0.37; p < 0.0001) and the risk of death by 23% (HR 0.77, 95% CI 0.67–0.88; p = 0.0002). Median investigator-assessed rPFS was 20.0 mo (95% CI 18.9–22.1) in the enzalutamide arm and 5.4 mo (95% CI 4.1–5.6) in the placebo arm. Median OS was 35.3 mo (95% CI 32.2–not yet reached) in the enzalutamide arm and 31.3 mo (95% CI 28.8–34.2) in the placebo arm. At the time of the OS analysis, 167 patients in the placebo arm had crossed over to receive enzalutamide. The most common adverse events in the enzalutamide arm were fatigue, back pain, constipation, and arthralgia. This final analysis of PREVAIL provides more complete assessment of the clinical benefit of enzalutamide. PREVAIL is registered on ClinicalTrials.gov as NCT01212991. Patient summary According to data from longer follow-up, enzalutamide continued to provide benefit over placebo in patients with metastatic castration-resistant prostate cancer.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Androgen receptor signaling inhibitor
- Enzalutamide
- Metastatic castration-resistant prostate cancer
- Overall survival
- Radiographic progression-free survival
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Beer, Tomasz M.
-
Armstrong, Andre ...
-
Rathkopf, Dana E
-
Loriot, Yohann
-
Sternberg, Cora ...
-
Higano, Celestia ...
-
visa fler...
-
Iversen, Peter
-
Evans, Christoph ...
-
Kim, Choung Soo
-
Kimura, Go
-
Miller, Kurt
-
Saad, Fred
-
Bjartell, Anders ...
-
Borre, Michael
-
Mulders, Peter
-
Tammela, Teuvo L ...
-
Parli, Teresa
-
Sari, Suha
-
van Os, Steve
-
Theeuwes, Ad
-
Tombal, Bertrand
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
European Urology
- Av lärosätet
-
Lunds universitet